ascorbic acid / Generic mfg. - LARVOL DELTA

Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer (clinicaltrials.gov) - P2 | N=50 | Terminated | Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Trial completion date: Jan 2030 ➔ Oct 2021 | Recruiting ➔ Terminated | Trial primary completion date: Jan 2024 ➔ Jul 2021; Based on the Data safety monitoring committee

Combination therapy • Trial completion date • Trial primary completion date • Trial termination • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor

The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis (clinicaltrials.gov) - P1 | N=160 | Not yet recruiting | Sponsor: King Abdulaziz University

New P1 trial • Chronic Kidney Disease • Movement Disorders • Nephrology • Renal Disease • Restless Legs Syndrome • Sleep Disorder